Difference between revisions of "About-cancer/treatment/clinical-trials/patient-safety/ending-trials-early/zh"
Jump to navigation
Jump to search
(Created page with "大多数临床试验从始至终都按计划进行。 但有时审判会提早终止。 例如,如果参与者遇到意想不到的严重副作用,或者有明显证据...") |
(Created page with "在某些情况下,由于以下原因,可能会停止试验:") |
||
Line 6: | Line 6: | ||
大多数临床试验从始至终都按计划进行。 但有时审判会提早终止。 例如,如果参与者遇到意想不到的严重副作用,或者有明显证据表明危害大于收益,则IRB和DSMB可能会停止试验。 | 大多数临床试验从始至终都按计划进行。 但有时审判会提早终止。 例如,如果参与者遇到意想不到的严重副作用,或者有明显证据表明危害大于收益,则IRB和DSMB可能会停止试验。 | ||
− | + | 在某些情况下,由于以下原因,可能会停止试验: | |
:*It is going very well. If there is clear evidence early-on that a new treatment or intervention is effective, then the trial may be halted so that the new treatment can be made widely available as soon as possible. | :*It is going very well. If there is clear evidence early-on that a new treatment or intervention is effective, then the trial may be halted so that the new treatment can be made widely available as soon as possible. |
Revision as of 10:09, 1 November 2019
尽早结束审判
查找临床试验
大多数临床试验从始至终都按计划进行。 但有时审判会提早终止。 例如,如果参与者遇到意想不到的严重副作用,或者有明显证据表明危害大于收益,则IRB和DSMB可能会停止试验。
在某些情况下,由于以下原因,可能会停止试验:
- It is going very well. If there is clear evidence early-on that a new treatment or intervention is effective, then the trial may be halted so that the new treatment can be made widely available as soon as possible.
- Enough patients cannot be recruited
- The results of other trials are published that answer the research question or make it irrelevant